Exagen (XGN)

• Market cap: $212M
• 1 day: -2.5%
• 5 days: -8.33%
• 1 month: -15.31%
• 3 months: -3.31%
• 6 months: 66.07%
• Year to date: 202.59%
• 1 year: 240%
• 5 years: -36.78%
• 10 years: -49.68%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Employees: 209